Heroin Dependence Clinical Trial
Official title:
Adjuvant Laser Meridian Massage in Heroin Addicts With Methadone Treatment: an Observational Case-controlled Study
A case-controlled study is conducted to investigate the effect of adjuvant laser meridian massage in heroin addicts with methadone treatment and establish the model of laser meridian massage treatment for drug addiction.
Objective: To investigate the effect of adjuvant laser meridian massage in heroin addicts
with methadone treatment and establish the model of laser meridian massage treatment for drug
addiction.
Methods: A case-controlled study is conducted. Fifteen male heroin addicts are enrolled from
Addiction Treatment Center as treatment group. They are treated with laser meridian massage
on the back including Bladder meridian and Governor vessel three times a week for 4 weeks. A
control group of participants without laser meridian massage treatment are matched by age.
Check urine morphine before, 2 and 4 weeks of treatment. Subjects report their times or days
of heroin use and self-fill Visual Analogue Scales of heroin craving / refusal of heroin use
(0-10 points) during last week before, 2 and 4 weeks of treatment. Subjects report their
quality of life using Short Form-12v2 before and 4 weeks of treatment. Obtain the subject's
pulse diagnosis and heart rate variability after a single treatment. Independent t test,
Mann-Whitney U test, chi-square test and Fisher's exact test were used to compare the
differences between the treatment and control groups. Repeated measures ANOVA, Generalized
estimating equations, paired t test and Wilcoxon Signed-Rank test were used for comparison
between the treatment and control groups.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00577408 -
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
|
Phase 3 | |
| Completed |
NCT00218309 -
Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
|
Phase 2 | |
| Completed |
NCT00000211 -
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
|
Phase 2 | |
| Completed |
NCT00000210 -
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
|
Phase 2 | |
| Completed |
NCT02324725 -
Biomarkers of Injectable Extended Release Naltrexone Treatment
|
Phase 4 | |
| Withdrawn |
NCT00000330 -
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
|
Phase 2 | |
| Completed |
NCT00249457 -
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2
|
N/A | |
| Completed |
NCT00218127 -
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
|
Phase 2 | |
| Completed |
NCT04133974 -
Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts
|
N/A | |
| Completed |
NCT00015288 -
Buprenorphine and Naloxone Combination Study - 10
|
Phase 1 | |
| Terminated |
NCT03711318 -
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
|
Phase 3 | |
| Recruiting |
NCT02541526 -
Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
|
Phase 3 | |
| Active, not recruiting |
NCT02541513 -
An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
|
Phase 3 | |
| Completed |
NCT01760473 -
Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
|
Phase 3 | |
| Terminated |
NCT01395797 -
Pioglitazone for Heroin and for Nicotine Dependence
|
Phase 1/Phase 2 | |
| Completed |
NCT01668706 -
Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts
|
N/A | |
| Active, not recruiting |
NCT00609089 -
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
|
Phase 1/Phase 2 | |
| Completed |
NCT00684840 -
Effects of Stress and Other Factors on Opiate Drug Choice.
|
N/A | |
| Completed |
NCT00759005 -
Effect of Stress on Heroin-Related Memory Retrieval
|
N/A | |
| Completed |
NCT00218530 -
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
|
Phase 1 |